Skip to main content
Top
Published in: International Urology and Nephrology 11/2016

01-11-2016 | Urology - Original Paper

Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidney

Authors: Ryan A. Hankins, Annerleim Walton-Diaz, Hong Truong, Joanna Shih, Gennady Bratslavsky, Peter A. Pinto, W. Marston Linehan, Adam R. Metwalli

Published in: International Urology and Nephrology | Issue 11/2016

Login to get access

Abstract

Objective

To identify renal function outcomes after robotic multiplex partial nephrectomy (RMxPNx), we reviewed our institutional database at the National Institutes of Health, National Cancer Institute. To our knowledge, we present the largest series of RMxPNx renal function outcomes to date. Robotic partial nephrectomy has been employed for oncologic control and to prevent dialysis dependence in hereditary multifocal renal cell carcinoma conditions. We have termed robotic surgery on a single kidney with three or more lesions a RMxPNx.

Materials and methods

We evaluated patients from a prospectively maintained database at a single institution (NIH/NCI) that underwent RMxPNx from 2007 to 2013. Demographic and operative data were compiled with statistical analysis with T test performed to determine renal function outcomes.

Results

A total of 54 patients underwent RMxPNx. Mean number of tumors removed was 8.63 (range 3–52). Mean preoperative creatinine and eGFR were 1.02 ± 0.26 mg/dL and 85.4 ± 21.5 mL/min, respectively. Postoperatively, creatinine increased from baseline by 0.45 mg/dL (p < 0.001). Similarly, a mean decrease in eGFR by 24.6 mL/min was observed (p < 0.001). At 3-month follow-up, the creatinine increase from baseline was 0.05 mg/dL (p = 0.10) and mean decrease in eGFR was 3.01 mL/min (p = 0.21). When stratifying based on preoperative CKD stages I–III, similar results were observed.

Conclusion

Robotic multiplex partial nephrectomy is a safe and feasible approach to patients with multifocal renal masses. These complex surgeries have a demonstrated learning curve, but this minimally invasive approach for nephron-sparing surgery allows patients to preserve renal function where they would otherwise require open surgery or a radical nephrectomy.
Literature
1.
go back to reference Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA (2008) Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol 53:514–523CrossRefPubMed Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA (2008) Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol 53:514–523CrossRefPubMed
2.
go back to reference Boris R, Proano M, Linehan WM, Pinto PA, Bratslavsky G (2009) Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol 182:1280–1286CrossRefPubMedPubMedCentral Boris R, Proano M, Linehan WM, Pinto PA, Bratslavsky G (2009) Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol 182:1280–1286CrossRefPubMedPubMedCentral
3.
go back to reference Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM (2001) Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 165:777–781CrossRefPubMed Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM (2001) Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 165:777–781CrossRefPubMed
4.
go back to reference Drachenberg DE, Mena OJ, Choyke PL, Linehan WM, Walther MM (2004) Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers. J Urol 172:49–53CrossRefPubMed Drachenberg DE, Mena OJ, Choyke PL, Linehan WM, Walther MM (2004) Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers. J Urol 172:49–53CrossRefPubMed
5.
go back to reference Liangkuan B, Zhang C, Li K, Fan X, Xu K, Han J, Huang H, Liu H, Dong W, Yang X, Huang J, Lin T (2013) Robotic partial nephrectomy for renal tumors larger than 4 cm: a systematic review and meta-analysis. Plus One 8:1–6 Liangkuan B, Zhang C, Li K, Fan X, Xu K, Han J, Huang H, Liu H, Dong W, Yang X, Huang J, Lin T (2013) Robotic partial nephrectomy for renal tumors larger than 4 cm: a systematic review and meta-analysis. Plus One 8:1–6
6.
go back to reference Rogers CG, Metwalli A, Blatt AM, Bratslavsky G, Menon M, Linehan WM, Pinto PA (2008) Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol 180:2353–2356CrossRefPubMedPubMedCentral Rogers CG, Metwalli A, Blatt AM, Bratslavsky G, Menon M, Linehan WM, Pinto PA (2008) Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol 180:2353–2356CrossRefPubMedPubMedCentral
7.
go back to reference Gong Y, Du C, Josephson DY, Wilson TG, Nelson R (2010) Four-arm robotic partial nephrectomy for complex renal cell carcinoma. World J Urol 28:111–115CrossRefPubMed Gong Y, Du C, Josephson DY, Wilson TG, Nelson R (2010) Four-arm robotic partial nephrectomy for complex renal cell carcinoma. World J Urol 28:111–115CrossRefPubMed
8.
go back to reference Borghesi M, Schiavina R, Gan M, Novara G, Mottrie A, Ficarra V (2013) Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses. World J Urol 31:499–504CrossRefPubMed Borghesi M, Schiavina R, Gan M, Novara G, Mottrie A, Ficarra V (2013) Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses. World J Urol 31:499–504CrossRefPubMed
9.
go back to reference Petros F, Sukumar S, Haber G, Dulabon L, Bhayani S, Stifelman M, Kaouk J, Rogers C (2012) Multi-institutional analysis of robot-assisted partial nephrectomy for renal tumors > 4 cm versus < 4 cm in 445 consecutive patients. J Endourol 26:642–646CrossRefPubMed Petros F, Sukumar S, Haber G, Dulabon L, Bhayani S, Stifelman M, Kaouk J, Rogers C (2012) Multi-institutional analysis of robot-assisted partial nephrectomy for renal tumors > 4 cm versus < 4 cm in 445 consecutive patients. J Endourol 26:642–646CrossRefPubMed
10.
go back to reference Ghani KR, Sukumar S, Sammon JD, Rogers CG, Trinh Q, Menon M (2013) Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: results from the nationwide inpatient sample. J Urol 191:1–7 Ghani KR, Sukumar S, Sammon JD, Rogers CG, Trinh Q, Menon M (2013) Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: results from the nationwide inpatient sample. J Urol 191:1–7
12.
go back to reference Fadahunsi AT, Sanford T, Linehan WM et al (2011) Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol 185:49–53CrossRefPubMed Fadahunsi AT, Sanford T, Linehan WM et al (2011) Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol 185:49–53CrossRefPubMed
13.
go back to reference Lane BR, Babineau DC, Poggio ED, Weight CJ, Larson BT, Gill IS, Novick AC (2008) Factors predicting renal functional outcome after partial nephrectomy. J Urol 180:2363–2369CrossRefPubMed Lane BR, Babineau DC, Poggio ED, Weight CJ, Larson BT, Gill IS, Novick AC (2008) Factors predicting renal functional outcome after partial nephrectomy. J Urol 180:2363–2369CrossRefPubMed
14.
go back to reference Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC (2011) Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. J Urol 79:356–360CrossRef Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC (2011) Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. J Urol 79:356–360CrossRef
15.
go back to reference Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM (2004) The relationship between renal tumor size and metastases in patients with von hippel-lindau disease. J Urol 172:63–65CrossRefPubMed Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM (2004) The relationship between renal tumor size and metastases in patients with von hippel-lindau disease. J Urol 172:63–65CrossRefPubMed
Metadata
Title
Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidney
Authors
Ryan A. Hankins
Annerleim Walton-Diaz
Hong Truong
Joanna Shih
Gennady Bratslavsky
Peter A. Pinto
W. Marston Linehan
Adam R. Metwalli
Publication date
01-11-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 11/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1392-y

Other articles of this Issue 11/2016

International Urology and Nephrology 11/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine